EligibleTrials

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

Recruiting · NCT06943469 · Interventional (participants receive a specific treatment) · Lead sponsor: Société des Produits Nestlé (SPN)

View the official record on ClinicalTrials.gov →
Eczema

Interventions studied

Control formulaTest formula

What this trial is about

The main purpose of this study is to assess the efficacy of a partially hydrolyzed formula with synbiotics in halting one of the first steps of the allergic march (atopic dermatitis) in infants at risk of allergy. Other efficacy and safety parameters will be assessed as well.

Who can take part

Age range
1 Day to 14 Days
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

25 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.